OpenVSafe by OpenVAERS
Search V-safe

AA9-24021-05385

3 vaccinations 3 coded responses 16 check-ins 3 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
875 / NM
Registered
2021-12-18
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2020-12-17
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-07
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-18
    Registered in v-safe
  4. 2021-12-18
    Dose 3 — Pfizer-BioNTech
  5. 2021-12-18
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-12-19
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-12-20
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  8. 2021-12-21
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  9. 2021-12-22
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  10. 2021-12-23
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  11. 2021-12-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  12. 2021-12-27
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  13. 2022-01-01
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  14. 2022-01-08
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  15. 2022-01-17
    Survey response — day 28, dose 3
    MedDRA: Rhinorrhoea — Feeling: Good
    Free text: Runny nose
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-01-22
    Survey response — day 35, dose 3
    MedDRA: Cough, Fatigue, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Cough runny nose fatigue
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-01-29
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-03-19
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  19. 2022-06-18
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  20. 2022-12-18
    Survey response — 12 months, dose 3
    MedDRA: Bronchitis, COVID-19, Respiratory syncytial virus infection — Feeling: Fair
    Free text: COVID in July RSV and bronchitis 10/2022
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-17Pfizer-BioNTech No
22021-01-07Pfizer-BioNTech No
32021-12-18Pfizer-BioNTech No

Free text

Release 10 — day 28, dose 3

2022-01-17

Symptoms: Runny nose

Release 11 — day 35, dose 3

2022-01-22

Symptoms: Cough runny nose fatigue

Release 12 — 12 months, dose 3

2022-12-18

Symptoms: COVID in July RSV and bronchitis 10/2022

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBronchitis · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDFatigue · · ✓
SDRespiratory syncytial virus infection · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…